Literature DB >> 23994032

Coronary artery disease and its risk factors in patients presenting for liver transplantation.

Edward Gologorsky1, Ernesto A Pretto2, Kyota Fukazawa2.   

Abstract

STUDY
OBJECTIVE: To determine the distribution of coronary artery disease (CAD) and its risk factors across the various etiologies of end-stage liver disease, and to elucidate the relationship between severe alcohol consumption and CAD.
DESIGN: Retrospective multicenter study analysis.
SETTING: National Standard Transplant Analysis and Research file data. MEASUREMENTS: Data from all primary adult orthotopic liver transplant recipients during the period from 2004 through 2006 were studied. Data were divided into 5 groups according to each patient's etiology of end-stage liver disease. The prevalence of CAD and the distribution of its risk factors were compared among groups. MAIN
RESULTS: 17,482 cases were studied. The incidence of CAD was highest in nonalcoholic hepatic steatosis (7.4%) and lowest in biliary cirrhosis (1.7%). No difference in prevalence of CAD and its risk factors was noted between the viral and alcoholic etiologies (Hepatitis C 2.7%, Hepatitis B 2.3%, and alcoholic cirrhosis 2.9%).
CONCLUSIONS: Prevalence of CAD and the distribution of CAD risk factors in patients with severe alcohol consumption were similar to patients with viral hepatitis. CAD was most prevalent in patients with hepatic steatosis. This study argues against the notion of decreased expression and progression of CAD in patients with alcoholic cirrhosis presenting for liver transplantation.
© 2013.

Entities:  

Keywords:  Anesthesia preoperative assessment; Coronary artery disease; Liver transplantation

Mesh:

Year:  2013        PMID: 23994032     DOI: 10.1016/j.jclinane.2013.06.001

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  6 in total

1.  Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?

Authors:  Karen V Danielsen; Signe Wiese; Jens Hove; Flemming Bendtsen; Søren Møller
Journal:  Dig Dis Sci       Date:  2018-03-08       Impact factor: 3.199

2.  Use of Computed Tomography Coronary Calcium Score for Coronary Artery Disease Risk Stratification During Liver Transplant Evaluation.

Authors:  Sabha Bhatti; Blanca Lizaola-Mayo; Mohammad Al-Shoha; Mauricio Garcia-Saenz-de-Sicilia; Fuad Habash; Karam Ayoub; Michael Karr; Zubair Ahmed; Daniel Borja-Cacho; Andres Duarte-Rojo
Journal:  J Clin Exp Hepatol       Date:  2021-08-21

3.  Favorable clinical outcome of nonalcoholic liver cirrhosis patients with coronary artery disease: A population-based study.

Authors:  Ming-Chang Tsai; Tzu-Wei Yang; Chi-Chih Wang; Yao-Tung Wang; Wen-Wei Sung; Ming-Hseng Tseng; Chun-Che Lin
Journal:  World J Gastroenterol       Date:  2018-08-21       Impact factor: 5.742

4.  Serum from Patients with Severe Alcoholic Liver Cirrhosis Inhibits Proliferation and Migration of Human Coronary Artery Smooth Muscle Cells.

Authors:  Mare Mechelinck; Miriam Peschel; Moriz A Habigt; Daniela Kroy; Michael Lehrke; Marius J Helmedag; Rolf Rossaint; Matthias Barton; Marc Hein
Journal:  J Clin Med       Date:  2021-11-23       Impact factor: 4.241

Review 5.  Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury.

Authors:  Irina Gîrleanu; Anca Trifan; Laura Huiban; Cristina Muzîca; Oana Cristina Petrea; Ana Maria Sîngeap; Camelia Cojocariu; Stefan Chiriac; Tudor Cuciureanu; Irina Iuliana Costache; Carol Stanciu
Journal:  Life (Basel)       Date:  2022-07-12

6.  "Dental Cluster" Versus "Metabolic Cluster": Analyzing the Associations of Planned and Delivered Dental Procedures with Metabolic Syndrome, Utilizing Data from the Dental, Oral, Medical Epidemiological (DOME) Cross-Sectional Record-Based Nationwide Study.

Authors:  Itzhak Abramovitz; Avraham Zini; Pablo Pribluda; Ron Kedem; Dorit Zur; Noam E Protter; Galit Almoznino
Journal:  Biology (Basel)       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.